The store will not work correctly when cookies are disabled.
2,7-dihydroxy-4-methyl-5-(3-(naphthalen-2-yl)phenyl)cyclohepta-2,4,6-trien-1-one
ID: ALA4573564
PubChem CID: 124132296
Max Phase: Preclinical
Molecular Formula: C24H18O3
Molecular Weight: 354.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(O)c(=O)c(O)cc1-c1cccc(-c2ccc3ccccc3c2)c1
Standard InChI: InChI=1S/C24H18O3/c1-15-11-22(25)24(27)23(26)14-21(15)20-8-4-7-18(13-20)19-10-9-16-5-2-3-6-17(16)12-19/h2-14H,1H3,(H2,25,26,27)
Standard InChI Key: SLQWBULJVNGZBQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
22.4959 -2.3427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2375 -1.9996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9760 -2.3623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3008 -3.1434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1527 -3.1630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8090 -3.7924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6313 -3.7983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2470 -1.1784 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.6190 -1.8580 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.8591 -1.8255 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.4482 -4.5298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9824 -4.5423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5102 -5.2148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8566 -5.9582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6758 -6.0282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1474 -5.3486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7985 -4.6079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9631 -5.4162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3120 -6.1605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1298 -6.2274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4291 -4.7420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2459 -4.8052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5959 -5.5509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4155 -5.6174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8860 -4.9432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5269 -4.1964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7084 -4.1335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 2 0
3 5 2 0
4 6 1 0
5 7 1 0
6 7 2 0
2 8 2 0
3 9 1 0
1 10 1 0
6 11 1 0
7 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
18 19 2 0
19 20 1 0
20 23 2 0
22 21 2 0
21 18 1 0
16 18 1 0
22 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 354.41 | Molecular Weight (Monoisotopic): 354.1256 | AlogP: 5.25 | #Rotatable Bonds: 2 |
Polar Surface Area: 57.53 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.12 | CX Basic pKa: ┄ | CX LogP: 5.24 | CX LogD: 5.24 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.52 | Np Likeness Score: 0.13 |
References
1. Berkowitz AJ, Franson AD, Gazquez Cassals A, Donald KA, Yu AJ, Garimallaprabhakaran AK, Morrison LA, Murelli RP.. (2019) Importance of lipophilicity for potent anti-herpes simplex virus-1 activity of α-hydroxytropolones., 10 (7): [PMID:31391890] [10.1039/C9MD00225A] |